Benzinga's Top Downgrades
January 12, 2015 at 08:43 AM EST
Analysts at Canaccord Genuity downgraded NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) from Buy to Hold. The price target for NPS ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.